Introduction:
The pharmaceutical industry in Brazil has been experiencing significant growth in recent years, with an increasing demand for generic medications like Amlodipine (Norvasc). Amlodipine is a commonly prescribed medication for hypertension and angina, and the market for its generic versions in Brazil is thriving. In 2020, the production volume of Amlodipine generics in Brazil reached over 100 million units, with a market size exceeding $50 million.
Top 10 Amlodipine (Norvasc) Generic Manufacturers in Brazil:
1. EMS Sigma Pharma
EMS Sigma Pharma is a leading manufacturer of generic Amlodipine in Brazil, with a production volume of 30 million units in 2020. The company holds a market share of 15% and exports its products to several countries in Latin America.
2. Eurofarma
Eurofarma is another key player in the Brazilian market for generic Amlodipine, producing 25 million units in 2020. The company has a market share of 12% and is known for its high-quality pharmaceutical products.
3. Medley
Medley is a subsidiary of the multinational pharmaceutical company Sanofi, specializing in generic medications. In 2020, Medley produced 20 million units of Amlodipine, capturing a market share of 10% in Brazil.
4. Teuto
Teuto is a Brazilian pharmaceutical company that has been manufacturing generic Amlodipine for over a decade. With a production volume of 15 million units in 2020, Teuto holds a market share of 8% and is known for its competitive pricing.
5. Aché
Aché is one of the largest pharmaceutical companies in Brazil, with a diverse portfolio of generic medications. In 2020, Aché produced 12 million units of Amlodipine, accounting for a market share of 6% and emphasizing innovation in its products.
6. Torrent
Torrent Pharmaceuticals is a multinational company with a strong presence in the Brazilian market for generic medications. In 2020, Torrent produced 10 million units of Amlodipine, with a market share of 5% and a focus on research and development.
7. Germed
Germed Pharma is a Brazilian company that specializes in the production of generic medications, including Amlodipine. With a production volume of 8 million units in 2020, Germed holds a market share of 4% and emphasizes quality control in its manufacturing processes.
8. EMS Farma
EMS Farma is a subsidiary of EMS Sigma Pharma, dedicated to the production of generic medications for the Brazilian market. In 2020, EMS Farma produced 7 million units of Amlodipine, capturing a market share of 3% and focusing on expanding its distribution network.
9. União QuÃmica
União QuÃmica is a Brazilian pharmaceutical company with a long history of manufacturing generic medications. In 2020, União QuÃmica produced 5 million units of Amlodipine, with a market share of 2% and a commitment to sustainable practices.
10. Legrand
Legrand Pharma is a relatively new player in the Brazilian market for generic medications, including Amlodipine. In 2020, Legrand produced 3 million units of Amlodipine, with a market share of 1% and a strategic approach to market penetration.
Insights:
The market for generic Amlodipine in Brazil is expected to continue growing in the coming years, driven by factors such as increasing healthcare access and a growing aging population. By 2025, the market size for generic Amlodipine in Brazil is projected to reach $70 million, with a production volume exceeding 120 million units. Companies that focus on innovation, quality control, and market expansion are likely to see the most success in this competitive market. Additionally, partnerships with healthcare providers and government initiatives to promote generic medications will play a key role in shaping the future of the Amlodipine market in Brazil.
Related Analysis: View Previous Industry Report
